Kissei Pharmaceutical Co., Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.15 USD
79.73 M USD
588.81 M USD
23.32 M
About Kissei Pharmaceutical Co., Ltd.
Sector
Industry
CEO
Mutsuo Kanzawa
Website
Headquarters
Matsumoto
Founded
1946
IPO date
Dec 22, 1988
Identifiers
2
ISIN JP3240600001
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KSPHF is 26.97 USD — it has decreased by −15.45% in the past 24 hours. Watch Kissei Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Kissei Pharmaceutical Co., Ltd. stocks are traded under the ticker KSPHF.
We've gathered analysts' opinions on Kissei Pharmaceutical Co., Ltd. future price: according to them, KSPHF price has a max estimate of 36.00 USD and a min estimate of 29.06 USD. Watch KSPHF chart and read a more detailed Kissei Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Kissei Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
KSPHF reached its all-time high on Nov 26, 2025 with the price of 31.90 USD, and its all-time low was 17.04 USD and was reached on Aug 18, 2022. View more price dynamics on KSPHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KSPHF stock is 18.28% volatile and has beta coefficient of 0.40. Track Kissei Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Kissei Pharmaceutical Co., Ltd. there?
Today Kissei Pharmaceutical Co., Ltd. has the market capitalization of 1.26 B, it has decreased by −3.25% over the last week.
Yes, you can track Kissei Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Kissei Pharmaceutical Co., Ltd. is going to release the next earnings report on May 12, 2026. Keep track of upcoming events with our Earnings Calendar.
KSPHF earnings for the last quarter are 0.50 USD per share, whereas the estimation was −0.25 USD resulting in a 302.51% surprise. The estimated earnings for the next quarter are 0.40 USD per share. See more details about Kissei Pharmaceutical Co., Ltd. earnings.
Kissei Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 171.02 M USD, despite the estimated figure of 159.97 M USD. In the next quarter, revenue is expected to reach 162.13 M USD.
KSPHF net income for the last quarter is 20.61 M USD, while the quarter before that showed 22.08 M USD of net income which accounts for −6.65% change. Track more Kissei Pharmaceutical Co., Ltd. financial stats to get the full picture.
Kissei Pharmaceutical Co., Ltd. dividend yield was 2.60% in 2024, and payout ratio reached 36.47%. The year before the numbers were 2.32% and 33.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 1.78 K employees. See our rating of the largest employees — is Kissei Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kissei Pharmaceutical Co., Ltd. EBITDA is 15.72 M USD, and current EBITDA margin is 11.97%. See more stats in Kissei Pharmaceutical Co., Ltd. financial statements.
Like other stocks, KSPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kissei Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kissei Pharmaceutical Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kissei Pharmaceutical Co., Ltd. stock shows the buy signal. See more of Kissei Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.